StockData
TG Therapeutics, Inc. logo

TG Therapeutics, Inc. (TGTX) stock

TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/303% above fair value
$66.12+3.41 (+5.44%)

Close on Nov 18, 2026Market cap $10.12BP/E 24.1Yield –

TG Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

TG Therapeutics's price to book ratio was 16.7× on Nov 11, 2026, against 8.5× a year earlier. Over the last 5 years it ranged from 3.6× to 145.0×, with a median of 16.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202616.7×+9.0
2025Dec 31, 20257.6×−16.8
2024Dec 31, 202424.4×+8.7
2023Dec 29, 202315.7×−1.4
2022Dec 30, 202217.1×+5.0
2021Apr 30, 202112.1×+3.1
2013Apr 30, 20139.0×+3.0
2012Dec 31, 20126.0×–

More TG Therapeutics figures

See a number that looks wrong?